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Abstract 
BACKGROUND: Cortisol is one of the important enzymes of saliva. Control of this hormone is an effective way to 
adjust the glucose level in diabetic patients.  
AIM: The aim of this research is to compare the salivary cortisol level in type 2 diabetic patients and pre-diabetics 
with healthy people. 
METHODS: In this case-control study (2018), the unstimulated salivary samples were collected from 44 patients 
with type 2 diabetes, 44 pre-diabetic people (case group), and 44 healthy subjects (control group), matched for 
age and gender. The samples were transferred to the laboratory, and salivary cortisol level was measured using 
ELISA. Data were analysed using SPSS 22 and Chi 2 tests. 
RESULTS: The mean salivary cortisol level in type 2 diabetic patients was 3.14 ± 1.17, in pre-diabetic cases was 
1.83 ± 0.68, and in healthy controls was 0.86 ± 0.43 (P < 0.001). The mean DMFT in type 2 diabetic patients was 
19.6 ± 6.5, in the pre-diabetic group was 13.43 ± 4.5, and in healthy controls was 9.38 ± 3.72 (P < 0.001). 
CONCLUSION: With regards to the results, salivary cortisol level in type 2 diabetic patients is more than pre-
diabetic people, and in pre-diabetic people is more than healthy people. Also, there was a significant relation 
between salivary cortisol level and DMFT index. 
 
 
 
 
Introduction 
 
Diabetes mellitus is a multi-agent metabolic 
disease characterised by increased blood glucose and 
metabolic disorders of carbohydrates, fat and protein 
[1]. Increased blood glucose results from impaired 
secretion of insulin and liver gluconeogenesis [2], [3]. 
Pre-diabetes is a condition in which blood glucose is 
somewhat high, but the patient does not have all the 
criteria for diabetes. Fasting blood glucose in pre-
diabetes is 100 to 125 mg/dL, while in diabetes, 
fasting blood glucose is 126 or above 126 mg/dL [4]. 
The two main types of diabetes include type 1 
diabetes (insulin-dependent) and type 2 diabetes 
(non-insulin dependent). The global prevalence of 
diabetes is increasing, and it’s predicted to reach from 
180 million in 2000 to 320 million in 2025 [5], [6]. The 
prevalence of diabetes in Iran is close to its global 
value as about 5.5% of the population [7]. 
Diabetes Mellitus has a very complex clinical 
presentation and is associated with complications 
such as nerve, kidney and retina damage and 
cardiovascular disease [8], [9]. The oral 
manifestations of diabetes are variable and are 
commonly manifested in patients with poorly 
controlled blood glucose. Some oral complications of 
diabetes include dry mouth, gingivitis, periodontitis, 
dental abscesses and soft tissue lesions of the tongue 
and oral mucosa [10], [11]. 
Diabetic patients need to control blood 
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glucose levels to diagnose, treat and track their 
illness. Typically, a blood sample for analysis is 
obtained through the vein or by finger stick or other 
aggressive methods which often result in physical and 
mental stress and pain in the patient. Because of this, 
the use of other biological fluids, such as saliva, is 
desirable to determine the level of glucose in the 
blood and avoid these invasive methods [12]. Salivary 
glands dysfunction is one of the problems that is 
commonly referred to by diabetic patients. This can be 
a direct result of the patient's medical condition and 
inadequate control of their blood glucose [13]. 
Therefore, many salivary compounds, such as 
enzymes, can be reliably considered for diagnosis and 
prognosis because saliva is readily available [14], 
[15], [16], [17]. 
Studies have shown that the determination of 
salivary combinations in diabetic patients can be 
useful in the detection and control of oral 
complications of diabetes [18], [19], [20]. One of the 
compounds in the saliva is cortisol. Cortisol is a 
glucocorticoid hormone secreted from the adrenal 
cortex and plays a role in regulating 
mineralocorticoids, immune system function, blood 
pressure and metabolism. Conditions such as 
hypertension, hypercholesterolemia, central obesity 
and glucose intolerance are associated with increased 
levels of cortisol. Following the changes in blood 
cortisol levels, the amount of this hormone also 
changes in the saliva [21], [22]. Salivary cortisol level 
has recently been suggested as a valuable 
recommendation for blood cortisol analyses. Given 
that this method is non-invasive and requires not 
much laboratory procedures, it can be investigated in 
unlimited cases [23]. Shirzaii et al., a study in 2016 
showed that salivary cortisol level is higher in people 
with type 2 diabetes compared to healthy subjects 
[24]. 
Dental caries is the most common disease 
which itself is the most common dental disease. In 
many cases, dental caries leads to tooth pulp 
infection, along with pain in the patient [25]. In 1938, a 
person by the name of Palmpour presented the DMFT 
index which was suggested by World Health 
Organization (WHO) and the International Dental 
Federation (FDI) to evaluate the variability of teeth 
health [26]. 
There are controversial reports about the role 
of cortisol in the aetiology of diabetes, and few studies 
have been conducted on the evaluation of salivary 
cortisol levels, and also there have been no studies on 
the evaluation of salivary cortisol levels in pre-diabetic 
patients and the relationship between salivary cortisol 
level and DMFT index. Therefore, the present study 
aimed to compare salivary cortisol level in diabetic 
and pre-diabetic individuals with healthy subjects and 
its relationship with DMFT index. 
 
 
Material and Methods 
 
This is a case-control study which was 
conducted on patients referring to the health centre of 
Sari city in 2018. The sample size was estimated as 
31 subjects for each group based on Shirzaii et al., 
study while considering the results of the study (mean 
and standard deviation of salivary cortisol levels in 
diabetic patients were 1.73 and 1.017 and 1.08 and 
0.643 in the control group respectively), confidence 
level of 95% and power of 90% were estimated using 
the formula for comparing the two meanings in the G-
power software. Regarding the fact that the number of 
studied groups was 3, the final sample size was 
adjusted according to the following formula, and it was 
determined as 132 subjects (44 in each group) [24].  
 
The ethics code to this research was 
considered as IR. MAZUMS. REC. 1397.1188 after 
being approved by the Medical Ethics Committee. 
Samples were selected by simple sampling method, 
and written consent was obtained from patients for 
participation in the study. In this study, subjects were 
divided into three groups with 44 subjects in each. 
The first group consisted of all people with type 2 
diabetes whose fasting blood glucose was 126 or 
greater than 126 mg/dL and had complete medical file 
and records and at least 5 years history of diabetes, 
had no other systemic diseases and weren’t taking 
any other medications other than glucose controlling 
ones. The second group consisted of pre-diabetic 
subjects whose fasting blood glucose was 100 to 125 
mg/dL and the third group consisted of healthy 
subjects without symptoms of diabetes (obesity and 
familial history of diabetes) or history of taking 
medications in the last three months that were 
matched with case group in terms of age and gender. 
Exclusion criteria included: Body Mass Index 
more than 30, pregnancy, tobacco use, drugs and 
alcohol, Addison's systemic disease, Cushing's 
syndrome and thyroid disorders, history of injury and 
surgery in the past four weeks, history of malignancy, 
use of corticosteroid or hormone therapy and mental 
and sleep disorders. 
All the participants had a blood test in the 
recent last month. All data, including gender, age, 
FBS, HbA1C and DMFT, were recorded. To evaluate 
the DMFT index, dental surfaces were dried using air 
syringe and carefully examined for the presence of 
tooth-coloured and non-tooth-coloured restorations. In 
this study, M represents the number of teeth lost due 
to decay. Whenever there is a lesion that appears on 
the smooth dental surfaces or inside pits and grooves 
that are embedded in the enamel or is softened on the 
floor and around it, the tooth is considered decayed 
(D). In this study, teeth that have cavities and are 
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dressed with temporary filling materials, as well as 
teeth with restorations that still contain caries are 
classified as Decayed teeth. Damaged teeth or 
treated decayed teeth whose appearance, function 
and size are restored to normal, are considered as 
Filled (F) which is referred to as the number of teeth 
that have undergone root canal therapies or are filled 
with restorative materials. After recording the 
mentioned items, the obtained numbers are summed, 
and the result determines the DMFT in each 
individual. The examination of teeth was conducted 
under the light on a dental chair [27]. 
To determine salivary cortisol level, subjects 
were asked not to eat, drink and brush 90 minutes 
before sampling. Subjects’ total non-stimulatory 
salivary samples (by spitting) were obtained while 
sitting on a chair upright with their head slightly tilted 
forwards in a calm environment between 10 to 12 A. 
M. (near the peak of serum cortisol level). The 
collected samples were immediately put into the 
numbered test tubes and transferred to the 
immunology laboratory of the Baghban clinic of Sari. 
At the laboratory, saliva samples were centrifuged at 
centrifugal speeds of 2000 rpm for 10 minutes, and 
then the supernatant was stored at -20°C until the 
test. The level of salivary cortisol was measured by 
ELISA method using the Diameter kit (made in Italy). 
  
 
Results 
 
In this study, 44 diabetic patients, 44 pre-
diabetics and 44 healthy people participated. There 
were 34 females (77.3%) and 10 males (22.7%) in all 
groups. The mean age in the diabetic group was 54 
years and 48/07 in the pre-diabetic group, and the 
healthy group it was 42.86 years. The mean FBS in 
the diabetic group was 188.91 mg/dL, in the pre-
diabetic group, it was 108.75 mg/dL, and in the 
healthy group it was 88.59 mg/dL. The mean salivary 
cortisol level in people with diabetes was reported as 
3.13 mmol/dL, in pre-diabetics as 1.83 mmol/dL and 
healthy subjects as 0.85 mmol/dL. The mean DMFT 
index in people with diabetes was 19.56, in pre-
diabetic individuals was 13.43, and in healthy subjects 
it was 9/38 (Table 1).  
Table 1: Specifications of participants in the study 
p-value Groups Mean ± Standard deviation Range Title 
< 0/100 
Diabetics group 54 ± 5.70 40-60 
Age (year) Pre-diabetics group 48.07 ± 8.68 31-60 
Healthy group 42.86 ± 11.90 30-60 
< 0/100 
Diabetics group 188.91 ± 48.91 126-342 
FBS (mg/Dl) 
Pre-diabetics group 
 
108.75 ± 7.78 100-124 
Healthy group 88.59 ± 7.49 70-99 
< 0/100 
Diabetics group 3.14 ± 1.17 1.4-6.8 
Cortisol 
(mmol/Dl) 
Pre-diabetics group 1.83 ± 0.68 0.2-3.1 
Healthy group 0.86 ± 0.43 0.3-1.8 
< 0/100 
Diabetics group 19.6 ± 6.5 10-28 
DMFT Pre-diabetics group 13.43 ± 4.5 6-28 
Healthy group 9.38 ± 3.72 4-18 
 
In a comparison between the two genders, 
the mean cortisol level in males was 2.34 mmol/dL, 
and in women it was 1.83 mmol/dL. According to the 
results, there is a significant difference in the cortisol 
levels between male and female diabetics (P = 0.005), 
but there are no significant differences in the cortisol 
levels between males and females in pre-diabetic and 
healthy groups (P = 0.051 and P = 0.624). In a 
comparison of cortisol levels between the three 
groups, the differences in salivary cortisol levels were 
significant among males (P < 0.001) and females (P < 
0.001) (Table 2). 
Table 2: Comparison of cortisol levels in both genders 
p-value Male Female Gender / Group 
*0.005 4.02 ± 1.42 2.88 ± 0.97 Diabetes 
0/051 2.2 ± 0.46 1.73 ± 0.69 Pre-diabetes 
0/624 0.8 ± 0.39 0.88 ± 0.44 Healthy 
0/046* 2.34 ± 1.59 1.83 ± 1.09 Total 
------ 
 *
< 0.001 
 *
< 0.001 p-value 
*p < 0.05. 
 
In a comparison of DMFT index between 
males and females, the mean DMFT index is 15.3 in 
males and 13.79 in females. According to the table 
below, there are no significant differences in the 
DMFT index between males and females in any of the 
participating groups. With the DMFT compared in the 
three groups, the DMFT index was significantly 
different among males (P < 0.001) and among 
females (P < 0.001) (Table 3). 
Table 3: Comparison of DMFT index in both genders 
p-value Male Female Gender / Group 
0/183 22 ± 5.39 18.5 ± 6.7 Diabetes 
0/396 14.5 ± 2.72 13.1 ± 4.8 Pre-diabetes 
0/935 9.3 ± 3.97 9.41 ± 3.7 healthy 
0/280 
15.6 
± 6.65 
13.79 
± 6.49 total 
--- 
 *
< 0.001 
 *
< 0.001 p-value 
*p < 0.05.  
 
Regarding HbA1C, diabetic subjects were 
divided into two subgroups of controlled diabetes (7 > 
HbA1C) and uncontrolled diabetes (7 < HbA1C) and 
cortisol levels and DMFT index were evaluated. In the 
comparison between the two subgroups, 12 subjects 
were in the controlled group and 32 in the 
uncontrolled group. The mean cortisol level in the 
controlled group was 3.03, and in the uncontrolled 
group it was 3.49, and its P-value was reported as 
0.94 by the Mann-Whitney test, which is statistically 
not significant. In a comparison of DMFT between the 
two groups, the mean DMFT was 16.83 in the 
controlled diabetes group and 20.6 in the uncontrolled 
diabetes group. Using the Mann-Whitney test, the P-
value was reported to be 0.86, which is statistically not 
significant (Table 4). 
Table 4: Comparison of cortisol levels and DMFT in diabetics 
group based on HbA1c levels in patients 
Cortisol level DMFT Number  
3.03 ± 0.74 16.83 ± 6.10 12 Controlled diabetes 
3.49 ± 1.29 20.59 ± 6.47 32 Uncontrolled diabetes 
0.124 0.89 --- p-value 
*p < 0.05. 
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Comparing the studied groups for age, FBS, 
salivary cortisol level and DMFT index, the results of 
the study showed a significant difference between the 
studied groups and the results are presented in Table 
5.  
Table 5: Significance level of inter-group relations 
Treatment groups P-value Age FBS Cortisol DMFT 
Healthy subjects & pre-diabetic patients *0.022 
 * 
< 0.001 
 * 
< 0.001 
 * 
< 0.001 
Healthy subjects & diabetic patients 
 * 
< 0.001
   *
< 0.001
  * 
< 0.001
  * 
< 0.001
 
Diabetic & pre-diabetic patients 
 * 
< 0.001
  * 
< 0.001
  * 
< 0.001
  * 
< 0.001
 
*p < 0.05. 
 
According to the results presented in Table 6, 
cortisol level was 0.97 units (P < 0.001) in pre-diabetic 
subjects and 2.28 (P < 0.001) in diabetic subjects 
higher than healthy subjects which are statistically 
significant. By adjusting the effects of variables such 
as age, gender and FBS, cortisol level in pre-diabetic 
subjects is 0.33 and in diabetic subjects is 0.62 units 
higher than healthy subjects, which is statistically 
significant. Based on the results of Kruskal-Wallis test, 
cortisol, as a dependent variable, as compared with 
independent variables in this study including gender, 
age, and FBS and significant results were reported. 
Based on the results of single-variable linear 
regression, for each unit of increase in age, cortisol 
level increases by 0.04 units, which was statistically 
significant (P < 0.001), but the effect of age on the 
cortisol level after adjusting other variables in this 
study was not statistically significant and 
considerable, and for each unit of increase in age, 
cortisol level decreases by 0.2 units (P = 0.713). In the 
assessment of the relationship between gender and 
salivary cortisol level, cortisol level in females was 
51.1 mmol/dl less than males, which is statistically 
significant (P = 0.046). After adjusting other variables 
in the study, cortisol level in females was 0.15 units 
lower than males, which is still statistically significant 
(P = 0.01). In the assessment of the relationship 
between FBS and salivary cortisol level, for each unit 
of increase in FBS, the cortisol level increases by 0.02 
units, which is reported as a significant relationship (P 
< 0.001). By adjusting the effects of other variables, 
the cortisol level increases by 0.28 units for each unit 
of increase in FBS, which is statistically significant (P 
= 0.006). 
Ultimately, in the assessment of the 
relationship between cortisol level and DMFT, the 
correlation coefficient between cortisol level and 
DMFT was 0.5, and this correlation is statistically 
significant (P < 0.001). 
Table 6: Investigation of factors related to cortisol level 
Single-variable 
analysis 
Multi-variable 
analysis 
Title 
Beta 
factor 
P-value 
Beta 
factor 
P-value Variables 
0.97  *<0.001 0.33  *<0.001 Pre-diabetics group (reference=healthy people) 
2.28  *<0.001 0.62  *<0.001 Diabetics group (reference=healthy people) 
0.04  *<0.001 -0.02 0.713 Age 
-0.51  *0.046 -0.15  *<0.010 Gender 
0.02  *<0.001 0.28 *0.006 FBS 
*p < 0.05. 
 
Discussion 
 
This study was conducted to compare the 
salivary cortisol levels between the diabetic, pre-
diabetic and healthy groups and also to investigate its 
relationship with DMFT. According to the results, the 
mean cortisol level in diabetic patients was higher 
than the pre-diabetic group and also in pre-diabetic 
group it was higher than in healthy subjects. These 
differences were statistically significant. Also, cortisol 
levels in patients with uncontrolled diabetes were 
more than those with diabetes, but this difference was 
not statistically significant. In a comparison between 
the two genders, the cortisol level in diabetic males 
was higher than diabetic females, but there were no 
significant differences in cortisol level between the two 
genders in the pre-diabetic and healthy group. 
Investigating the DMFT index, the mean 
DMFT in diabetic patients was higher than pre-
diabetic patients, and in pre-diabetic patients, it was 
higher than healthy subjects making these differences 
significant. In a comparison between the two genders, 
there were no significant differences in the DMFT 
index between males and females. There is a 
significant relationship between the mean DMFT and 
salivary cortisol levels in the studied subjects. 
There have been some studies about the 
relationship between the blood glucose and salivary 
cortisol level increase, which are reviewed: 
According to a study by Shirzaii et al., in 
Zahedan in 2016 with the aim of comparing salivary 
cortisol levels in type 2 controlled diabetic patients 
with healthy subjects, the mean salivary cortisol level 
in type 2 diabetic patients was 1.73 and in healthy 
subjects it was reported as 1/08 and it has been 
stated that there is a significant relationship between 
them and the mean cortisol level in diabetic patients 
was higher than healthy subjects. This result is similar 
to the present study. There have been no significant 
differences in the cortisol level in Shirzaii study 
between the two genders. Also, in this study cortisol 
levels in diabetic patients have been reported higher 
than Shirzaii study which is due to differences in 
sampling conditions, geographical location, and living 
conditions of the studied subjects [24]. 
In a study by Chiodini et al., In Italy in 2007, 
with the aim of evaluating salivary cortisol secretion in 
type 2 diabetic patients, the hypothalamus-pituitary-
adrenal axis activity and cortisol secretion in diabetic 
patients was higher than healthy subjects (0001 > P) 
and it’s been stated that it depends on the 
complications of diabetes. In this study, factors such 
as gender, duration of diabetes and HbA1c levels are 
deemed affect cortisol levels. These results are similar 
to the results of the current study with the difference 
that in Chiodini study no tests were conducted about 
pre-diabetic subjects [28]. 
In a study by Roy et al., 1990 regarding 
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hypothalamic-pituitary-adrenal axis disorder in 
diabetic patients, glucocorticoid and cortisol secretion 
were higher in patients with type 2 diabetes mellitus 
and insulin resistance. Regarding this study, an 
increase in cortisol secretion leads to diabetes and 
makes metabolic control difficult. In the current study, 
similar to Roy study, cortisol secretion has been 
observed to be higher in people with diabetes than 
healthy subjects, but no results on the effects of 
cortisol secretion on diabetes occurrence have been 
achieved [29]. 
In a study by Liu et al., in the United States in 
2005 regarding the level of salivary cortisol in soldiers 
with diabetes, similar to the current study, there is an 
increase in cortisol levels in diabetic patients [30]. 
In 1998, Roy et al., in a study on cortisol 
levels in diabetic subjects, found that diabetic patients 
with retinal damage and cardiovascular complications 
had higher levels of cortisol. They have pointed to 
rising cortisol levels in diabetic patients. However, the 
current study suggests that cortisol levels may still 
increase even if no diabetes complications occur, and 
blood glucose control is adequate [31]. 
In another study by Hackett et al., In 2014 
about the association between the daily pattern of 
cortisol and type 2 diabetes, it was concluded that 
salivary cortisol levels in patients with type 2 diabetes 
increase only during sleep and is not much changed 
during the day, while the current study showed that 
salivary cortisol levels increase significantly in the 
morning compared to non-diabetic subjects. 
Measuring salivary cortisol levels frequently in a day 
can justify these differences [32]. 
Radahmadi et al., in a similar study in 2004 
on the effects of psychical stress on exacerbation of 
diabetes mellitus, serum glucose, cortisol levels and 
body mass in rats found that cortisol secretion levels 
in people with diabetes mellitus increased significantly 
and the effects of diabetes on cortisol secretion is 
more than mental stress. Diabetes mellitus is a strong 
stimulant for the physiological system of the body [33]. 
All of the studies mentioned above have been 
based on the correlation between cortisol and blood 
glucose in diabetic patients and no studies have been 
conducted on pre-diabetic patients. According to our 
study, an increase in blood glucose levels in pre-
diabetes may also increase salivary cortisol levels. 
One of the oral complications of diabetes is 
dry mouth and increased glucose level of gingival 
crevicular fluid, which can increase dental caries 
occurrence. Another result of our study is the increase 
in DMFT in diabetic patients, which is reviewed in the 
following in some similar studies. 
According to a study by Behbahani and Yasin 
in Ahvaz in 2017 with the aim of determining the 
relationship between DMFT index, FBS and HbA1C in 
type 2 diabetic patients, it is stated that there is a 
significant relationship between DMFT and blood 
glucose which is similar to the results of the current 
study. The prevalence of DMFT in the Behbahani 
study was 51.51, which is slightly lower than the 
current study. This difference can be due to 
differences in culture and the degree of oral hygiene 
in that area [34]. 
In 2010 in a study on the impact of diabetes 
on the prevalence of dental problems, Miko et al. 
stated that poor blood glucose control and preterm 
diabetes could increase the risk of dental caries. This 
finding is consistent with the results of the current 
study [35]. 
In a study by Miralles et al., in 2006 on the 
effects of systemic factors of diabetes on the 
development of dental caries, diabetes mellitus has 
been shown to increase dental caries, and dental 
caries has been more common in the diabetic 
population. These results are similar to the results of 
the current study [36]. 
All of the above studies have been conducted 
to investigate the relationship between diabetes and 
DMFT, but no studies have been done about the 
relationship between diabetes and DMFT on pre-
diabetic subjects. According to the present study, it 
seems that increased blood sugar even in pre-
diabetics may increase DMFT and pre-diabetes is a 
risk factor for dental caries. 
Another finding from the present study is the 
relationship between salivary cortisol levels and 
DMFT. In a study by Golestannezhad et al., in Isfahan 
in 2014 on dental caries rampancy in patients with 
migraine, it has been stated that during migraine 
attacks, due to increased activity of the hypothalamus-
pituitary-adrenal axis, salivary cortisol levels increase. 
It has also been stated that there is a significant 
relationship between migraine and increased dental 
caries [37]. 
The mentioned study above indirectly points 
out the relationship between cortisol and DMFT, but 
no studies have been done to assess the relationship 
between salivary cortisol levels and DMFT index so 
far. According to the findings of the current study, 
there is a significant relationship between salivary 
cortisol levels and DMFT index, and it seems that 
increased salivary cortisol levels increase the risk of 
dental caries. The exact mechanism of this 
association is unclear, but increased cortisol levels 
may increase the risk of dental caries by increasing 
the amount of glucose in the gingival crevicular fluid in 
diabetic and pre-diabetic subjects. 
In a study by Farahat et al., in Yazd in 2013, 
on the status of DMFT index in patients with type 2 
diabetes and its relationship with HbA1C, it has been 
observed that DMFT index in patients with 
uncontrolled diabetes is significantly higher than 
patients with controlled diabetes. In the present study, 
DMFT is higher in patients with uncontrolled diabetes 
than in patients with controlled diabetes, but this 
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difference was not statistically significant [38]. Also, no 
significant differences were found between salivary 
cortisol levels in these two groups, and no studies 
have been done on this issue so far. 
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